171 related articles for article (PubMed ID: 28795582)
1. Current status of bioanalytical outsourcing: a pharma perspective.
Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
[TBL] [Abstract][Full Text] [Related]
2. Outsourcing in bioanalysis: a CRO perspective.
Lowes S
Bioanalysis; 2017 Aug; 9(15):1161-1164. PubMed ID: 28829186
[TBL] [Abstract][Full Text] [Related]
3. The evolution of the Pharma-CRO working relationship: AstraZeneca and Covance.
Bioanalysis; 2017 Aug; 9(15):1171-1174. PubMed ID: 28795581
[TBL] [Abstract][Full Text] [Related]
4. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
Dillen L; Verhaeghe T
Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
[TBL] [Abstract][Full Text] [Related]
5. Bioanalytical outsourcing: transitioning from Pharma to CRO.
Hayes R
Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
[No Abstract] [Full Text] [Related]
6. Bioanalytical outsourcing models in pharmaceutical companies.
Zimmer D
Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
[No Abstract] [Full Text] [Related]
7. Perspectives on the draft ICH-M10 guidance: an interview with Eric J Woolf.
J Woolf E
Bioanalysis; 2019 Aug; 11(15):1387-1388. PubMed ID: 31490111
[TBL] [Abstract][Full Text] [Related]
8. The changing world of bioanalysis: summary of panel discussions.
Spooner N; Anderson M; Dillen L; Ferrari L; Hilhorst M; Lam Z; Michi M; Munday J; Smeraglia J; Summerfield S; Zimmer D
Bioanalysis; 2017 Aug; 9(15):1175-1179. PubMed ID: 28763241
[No Abstract] [Full Text] [Related]
9. Bioanalytical outsourcing: the two sides of the medal.
Zimmer D
Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
[No Abstract] [Full Text] [Related]
10. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
Abberley L
Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
[No Abstract] [Full Text] [Related]
11. An overview of the China Bioanalytical Forum: interview with Daniel Tang.
Tang D
Bioanalysis; 2017 Feb; 9(4):333-335. PubMed ID: 28102698
[TBL] [Abstract][Full Text] [Related]
12. AstraZeneca and Covance Laboratories Clinical Bioanalysis Alliance: an evolutionary outsourcing model.
Arfvidsson C; Severin P; Holmes V; Mitchell R; Bailey C; Cape S; Li Y; Harter T
Bioanalysis; 2017 Aug; 9(15):1181-1194. PubMed ID: 28762755
[TBL] [Abstract][Full Text] [Related]
13. Global outsourcing.
Garofolo W; Garofolo F
Bioanalysis; 2010 Feb; 2(2):149-52. PubMed ID: 21083294
[No Abstract] [Full Text] [Related]
14. Bioanalytical method transfer considerations of chromatographic-based assays.
Williard CV
Bioanalysis; 2016 Jul; 8(13):1409-13. PubMed ID: 27277876
[TBL] [Abstract][Full Text] [Related]
15. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
[TBL] [Abstract][Full Text] [Related]
16. Meeting the challenges of bioanalytical outsourcing: understanding the hidden cost of price pressure.
Bennett P
Bioanalysis; 2011 Nov; 3(22):2491-3. PubMed ID: 22122596
[No Abstract] [Full Text] [Related]
17. Outsourcing discovery.
Mallapaty S
Nature; 2017 Dec; 552(7683):S5. PubMed ID: 29219992
[No Abstract] [Full Text] [Related]
18. Perspectives on the draft ICH M10 guidance: an interview with Kelly Dong.
Dong K
Bioanalysis; 2019 Nov; 11(22):2025-2026. PubMed ID: 31645114
[TBL] [Abstract][Full Text] [Related]
19. The quiet revolution: outsourcing in pharma.
Crossley R
Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
[No Abstract] [Full Text] [Related]
20. Efficient interactions with bioanalytical contract research organizations: inside scoop.
Tan A; Fanaras C; Fanaras JC
Bioanalysis; 2022 Aug; 14(16):1081-1084. PubMed ID: 36194671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
